Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

Thu, 15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

----------

FTSE 100

----------

Credit Suisse cuts AstraZeneca to 'neutral' (outperform) - price target 11,000 pence

----------

Credit Suisse raises GSK to 'neutral' (underperform) - price target 1,430 (1,630) pence

----------

Jefferies cuts Hikma Pharmaceutical price target to 2020 (2290) pence - 'buy'

----------

Berenberg cuts Admiral Group price target to 2,819 (2,903) pence - 'buy'

----------

Berenberg raises InterContinental Hotels target to 6,500 (5,700) pence - 'buy'

----------

Barclays cuts Whitbread price target to 3,500 (4,000) pence - 'overweight'

----------

Berenberg cuts Howden Joinery group price target to 620 (780) pence - 'hold'

----------

RBC cuts Dechra Pharma price target to 4,000 (4,200) pence - 'outperform'

----------

HSBC raises BT Group to 'buy' (hold)

----------

FTSE 250

----------

JPMorgan raises Trainline price target to 425 (420) pence - 'neutral'

----------

Berenberg cuts Volution price target to 460 (550) pence - 'buy'

----------

Berenberg cuts Travis Perkins price target to 910 (1,000) pence - 'hold'

----------

Berenberg cuts Marshalls price target to 380 (400) pence - 'hold'

----------

Berenberg cuts Ibstock price target to 180 (210) pence - 'hold'

----------

Berenberg cuts Genuit price target to 470 (530) pence - 'buy'

----------

Berenberg starts Currys with 'hold' - price target 70 pence

----------

Barclays cuts John Wood Group price target to 250 (320) pence - 'overweight'

----------

Barclays cuts C&C Group price target to 230 (240) pence - 'overweight'

----------

Citigroup raises Tate & Lyle to 'buy' (neutral) - price target 850 pence

----------

Goldman Sachs cuts Marks & Spencer price target to 125 (140) pence - 'sell'

----------

Jefferies cuts Redrow price target to 768 (780) pence - 'buy'

----------

SMALL CAP

----------

Morgan Stanley raises AIB target to 3 (2,80) EUR - 'equal-weight'

----------

Morgan Stanley raises Bank of Ireland target to 7,60 (7,40) EUR - 'equal-weight'

----------

Jefferies cuts DFS Furniture price target to 210 (270) pence - 'buy'

----------

Berenberg cuts Eurocell price target to 250 (310) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 300 (310) pence - 'buy'

----------

Berenberg cuts Forterra price target to 250 (270) pence - 'hold'

----------

Berenberg cuts Breedon price target to 80 (100) pence - 'buy'

----------

Goldman Sachs cuts ITM Power price target to 120 (220) pence - 'sell'

----------

HSBC cuts Johnson Service Group to 'hold' (buy)

----------

Bank of America raises Fevertree Drinks price target to 1,030 (950) pence - 'neutral'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Jan 2022 12:19

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

Read more
11 Jan 2022 09:06

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook

Read more
11 Jan 2022 08:41

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug

Read more
11 Jan 2022 07:55

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises

Read more
4 Jan 2022 11:47

Dechra slumps as Exane highlights 'punchy valuation'

(Sharecast News) - Dechra Pharmaceuticals was under the cosh on Tuesday after Exane BNP Paribas initiated coverage of the stock at 'neutral' on valuation grounds.

Read more
4 Jan 2022 10:36

LONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK

LONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK

Read more
4 Jan 2022 08:16

LONDON BRIEFING: dim t restaurant operator gives taste of Omicron hit

LONDON BRIEFING: dim t restaurant operator gives taste of Omicron hit

Read more
3 Dec 2021 09:44

LONDON BROKER RATINGS: Jefferies ups SSE, AJ Bell; Deutsche likes BP

LONDON BROKER RATINGS: Jefferies ups SSE, AJ Bell; Deutsche likes BP

Read more
1 Dec 2021 18:05

TOP NEWS: Electrocomponents, Dechra oust Darktrace and Johnson Matthey

TOP NEWS: Electrocomponents, Dechra oust Darktrace and Johnson Matthey

Read more
1 Dec 2021 14:44

Electrocomponents set for FTSE 100 as a founding member is seen ousted

Electrocomponents set for FTSE 100 as a founding member is seen ousted

Read more
23 Nov 2021 18:12

Dechra and Electrocomponents could be elevated to FTSE 100

Dechra and Electrocomponents could be elevated to FTSE 100

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
19 Nov 2021 07:34

Dechra Pharma selects Alison Platt as next chair

(Sharecast News) - Dechra Pharmaceuticals has selected Alison Platt to chair the board when Tony Rice steps down at the end of 2021.

Read more
12 Nov 2021 16:43

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.